In the mice with NAFLD, SSd reduced levels of serum ALT, AST, triglycerides, FABP4, and SREBP1 mRNA, as well as the expression of ER-stress-related proteins. This evidence concerns the gene FABP4 and metabolic dysfunction-associated steatotic liver disease.